COVID-19 vaccination provides protection against serious illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death. Bivalent COVID-19 vaccines, containing original and Omicron BA.4/5 spike protein components, help restore protection that has waned since previous vaccination. During this COCA Call, presenters will discuss updates on bivalent vaccines including the most recent vaccine effectiveness data, the Centers for Disease Control and Prevention’s clinical guidance for bivalent vaccines, and strategies for communicating with patients about COVID-19 vaccination.

If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.

The slide set will be available on the day of the call on the COCA Call webpage under Call Materials.

Free Continuing Education (CE) will be offered for this COCA Call.

Registration is not required.

Call Information